Minneapolis-based medical device manufacturer Medtronic has a straightforward, six-word mission: Alleviate pain, restore health, extend life.
That mission has served the company well. From its formation as the inventor and producer of the world's first implantable pacemaker in the 1950s, Medtronic now makes devices that treat 70 different conditions, has sales in more than 150 countries, and does business in 60 currencies. However, as it grew into a global organization, its foreign exchange (FX) risk management processes began causing pain, not alleviating it.
Continue Reading for Free
Register and gain access to:
- Thought leadership on regulatory changes, economic trends, corporate success stories, and tactical solutions for treasurers, CFOs, risk managers, controllers, and other finance professionals
- Informative weekly newsletter featuring news, analysis, real-world cas studies, and other critical content
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the employee benefits and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
*May exclude premium content
Already have an account?
Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Meg Waters
Meg Waters is the editor in chief of Treasury & Risk. She is the former editor in chief of BPM Magazine and the former managing editor of Business Finance.
